Expertise in
2
conditions

Jan Gutermuth

Brussels, BRU, BE 
Expertise in
2
conditions
Brussels, BRU, BE 

Overview

Jan Gutermuth practices practicing medicine in Brussels, Belgium.

Gutermuth is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Atopic Dermatitis, Anaphylaxis, Hives, and Localized Scleroderma.

They are actively involved in clinical research, co-authoring 107 peer reviewed articles and participating in 1 clinical trial.

Locations

Brussels, BRU, Belgium
Other Locations
Jette, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drugs: Baricitinib, Corticosteroid
Study Phase: Phase 3

107 Total Publications

Response to letter to the editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.
Response to letter to the editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: August 04, 2026

Frequently Asked Questions about Jan Gutermuth

Is Jan Gutermuth a top-rated expert for Atopic Dermatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Jan Gutermuth is classified as an Distinguished expert for Atopic Dermatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jan Gutermuth participate in research or clinical trials?

Yes. Jan Gutermuth has published 107 articles and abstracts on conditions like Atopic Dermatitis. You can view a list of Jan Gutermuth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gutermuth's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile